Northwest Bio is near 5-year lows with DCVax vaccine in review. Mixed opinions on trial, but potential remains. Cash issues ...

Josep M. Llovet, MD, PhD, describes the phase 3 LEAP-012 clinical study, including its methods, design, and enrollment criteria.

Morgan Stanley analyst Maxwell Skor has maintained their neutral stance on RPTX stock, giving a Hold rating yesterday.Pick the best stocks and ...

According to real-world data, no survival advantage was seen when comparing 3 frontline CDK4/6 inhibitor combinations in ...

It’s safe to say that stock investors are closing out 2024 in a rather upbeat mood. The markets posted substantial gains, ...